Medicine
Thyquidity 100 mcg/5 mL oral solution
Thyquidity 100 mcg/5 mL oral solution is a prescription medicine containing Levothyroxine for oral use, marketed by Oliva Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store and dispense…
Key facts
- Active ingredient (INN)
- Levothyroxine
- Brand
- Thyquidity
- Strength
- 100 mcg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 1 bottle, 2 bottles
- Marketing authorisation holder
- Oliva Therapeutics
- Manufacturer
- Oliva Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store and dispense in original bottle.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H03AA01 Levothyroxine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2025
- Identifiers
- RxCUI 2473276, 2473282DailyMed set ID 0c839877-50e4-455f-9b6c-462efb09cb96NDC 82685-360Application NDA214047
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 82685-360-01 | Oliva Therapeutics | 1 July 2025 |
| 2 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 82685-360-02 | Oliva Therapeutics | 1 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 August 2000 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Levothyroxine
Clinical summary
Levothyroxine is a l-thyroxine. It is available as tablets, capsules and powder for injection for oral and intravenous use. MedsAcross supplies Levothyroxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LevothyroxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Levothyroxine Sodium prescribing information (Amneal Pharmaceuticals NY) · U.S. National Library of Medicine, DailyMed
Need Thyquidity 100 mcg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.